A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia.
Misam ZawitCarmelo GurnariSimona PagliucaHassan AwadaJaroslaw P MaciejewskiYogen SaunthararajahPublished in: Clinical case reports (2021)
We report on a novel, successful, non-cytotoxic therapy to treat multiply-refractory T-LGL in an elderly patient.